XTalks

DECEMBER 20, 2023

In 2024, pharma companies and emerging biotechs will improve candidate safety profiles and reduce off-target effects by exploiting predictive intelligence unlocked by AI,” she predicts. These companies are at various stages of research and clinical trials.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

DECEMBER 13, 2023

Now, let’s delve into the list of the top ten fastest growing biotech companies in 2023, ranked by their compound annual growth rate (CAGR). These companies were identified through The Americas’ Fastest-Growing Companies 2023 list by the Financial Times.

Genetics 111

Genetics Vaccination Vaccine DNA 111

pharmaphorum

OCTOBER 12, 2022

Overall, the aim is to improve the efficiency of drug discovery by identifying genetic variants that contribute to human disease in omics data – a broad category that includes DNA profiles, gene transcripts, and protein expression.

Genomics 64

Genomics Genome DNA Drugs 64

pharmaphorum

OCTOBER 18, 2022

US-based Tempus has built a precision medicine platform – powered by artificial intelligence and machine learning – that sifts through a large library of anonymised patient data, including results of clinical, molecular, and genomic testing.

Production 52

Production Clinical Trials Clinical Trials Genomics 52

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

SEPTEMBER 7, 2022

The industry may need to carry out behavioural studies to better understand how to recruit and involve these populations, as it is crucial to understand the genetic differences between demographics. The same is true for Asian and Hispanic populations.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Genetics 98

Pharma Marketing Network

OCTOBER 17, 2024

Moreover, the adoption of digital tools like mobile apps and telemedicine platforms is facilitating direct communication between pharma companies and end-users. As patients become more digitally savvy, pharma companies are investing in creating seamless digital experiences that cater to their needs and preferences.

Marketing 52

Marketing Pharma Companies Regulation Production 52

XTalks

OCTOBER 15, 2021

The Lacks family is also concerned over the wide availability of Lacks’ genetic material, saying that “some of the most private information about Ms. However, the agreement did not include a share of any profits that researchers or pharma companies may make from use of the cells.

Vaccination 105

Vaccination Vaccine Gene Mapping Doctors 105

pharmaphorum

APRIL 7, 2022

Novartis’ generics unit Sandoz has moved on to the next stage of a collaboration with Ares Genetics, which is focusing on the use of artificial intelligence to track antimicrobial resistance (AMR), improve diagnoses and guide the most effective use of antibiotics. “AMR, which is now estimated to directly account for nearly 1.3

Bioinformatics 52

Bioinformatics Genetics Genomics Genome 52

pharmaphorum

MARCH 30, 2021

Alexion is a somewhat unique pharma company in that it focuses almost entirely on rare diseases – and although this is an immensely challenging area to operate in, the company’s senior vice president of its international business, Camilla Harder Hartvig, says it provides an unparalleled “sense of mission”.

Genetics 111

Genetics Marketing Development Genomics 111

Pharma Marketing Network

OCTOBER 14, 2024

These technologies enable pharmaceutical companies to analyze vast amounts of data quickly, identify potential drug candidates, and optimize clinical trials, ultimately accelerating the time-to-market for new therapies. Content marketing is another powerful tool in the pharma marketer’s arsenal.

Marketing 52

Marketing Branding Big Data Drugs 52

pharmaphorum

DECEMBER 6, 2022

A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped. According to Genomics England , the project saw 18.5% Aims for the project.

Genome Project 98

Genome Project Research Genomics Genome 98

pharmaphorum

SEPTEMBER 1, 2020

The 2010s have seen the development of innovative new classes of medicines, building on the greater understanding of the body since the genome was first sequenced at the end of the last century. This knowledge of genetics and the underlying cause of many diseases, including cancer, has resulted in powerful new drugs.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

Pharmaceutical Technology

MARCH 20, 2023

Pharma companies and world health stand to benefit from new technologies, but it’s a tough time to be an investor – and an even tougher one for firms seeking investment. One significant growth area is the rise of genomics. Further rate hikes could be on the way this year.

Gene Therapy 225

Gene Therapy Genomics Genome Gene 225

XTalks

JANUARY 6, 2025

Additionally, CRISPR genome-wide screening holds great potential for identifying key disease-associated genes and uncovering novel therapeutic targets. Furthermore, CRISPR/Cas9 presents a promising avenue for overcoming genetic diseases in the near future. By 2025 , 10 to 20 new gene therapies are expected to gain approval each year.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111